Skip to Content

M C53 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg)

Pill with imprint M C53 is Green, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M C53

Carbidopa and levodopa (orally disintegrating) 25 mg / 250 mg M C53
Carbidopa and levodopa (orally disintegrating) 25 mg / 250 mg M C53
Carbidopa and levodopa (orally disintegrating) 25 mg / 250 mg M C53

Carbidopa and Levodopa (Orally Disintegrating)

Imprint
M C53
Strength
25 mg / 250 mg
Color
Green
Size
15.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5053
Inactive Ingredients
aspartame, mannitol, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate, sorbitol, FD&C Blue No. 1, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.